Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Recommendations for respiratory syncytial virus surveillance at the national level

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Teirlinck, AC, Broberg, EK, Berg, AS, Campbell, H, Reeves, RM, Carnahan, A, Lina, B, Pakarna, G, Bøås, H, Nohynek, H, Emborg, H-D, Nair, H, Reiche, J, Oliva, JA, Gorman, JO, Paget, J, Szymanski, K, Danis, K, Socan, M, Gijon, M, Rapp, M, Havlíčková, M, Trebbien, R, Guiomar, R, Hirve, SS, Buda, S, van der Werf, S, Meijer, A & Fischer, TK 2021, 'Recommendations for respiratory syncytial virus surveillance at the national level', The European respiratory journal, bind 58, nr. 3, 2003766. https://doi.org/10.1183/13993003.03766-2020

APA

Teirlinck, A. C., Broberg, E. K., Berg, A. S., Campbell, H., Reeves, R. M., Carnahan, A., Lina, B., Pakarna, G., Bøås, H., Nohynek, H., Emborg, H-D., Nair, H., Reiche, J., Oliva, J. A., Gorman, J. O., Paget, J., Szymanski, K., Danis, K., Socan, M., ... Fischer, T. K. (2021). Recommendations for respiratory syncytial virus surveillance at the national level. The European respiratory journal, 58(3), [2003766]. https://doi.org/10.1183/13993003.03766-2020

CBE

Teirlinck AC, Broberg EK, Berg AS, Campbell H, Reeves RM, Carnahan A, Lina B, Pakarna G, Bøås H, Nohynek H, Emborg H-D, Nair H, Reiche J, Oliva JA, Gorman JO, Paget J, Szymanski K, Danis K, Socan M, Gijon M, Rapp M, Havlíčková M, Trebbien R, Guiomar R, Hirve SS, Buda S, van der Werf S, Meijer A, Fischer TK. 2021. Recommendations for respiratory syncytial virus surveillance at the national level. The European respiratory journal. 58(3):Article 2003766. https://doi.org/10.1183/13993003.03766-2020

MLA

Vancouver

Author

Teirlinck, Anne C ; Broberg, Eeva K ; Berg, Are Stuwitz ; Campbell, Harry ; Reeves, Rachel M ; Carnahan, AnnaSara ; Lina, Bruno ; Pakarna, Gatis ; Bøås, Håkon ; Nohynek, Hanna ; Emborg, Hanne-Dorthe ; Nair, Harish ; Reiche, Janine ; Oliva, Jesus Angel ; Gorman, Joanne O ; Paget, John ; Szymanski, Karol ; Danis, Kostas ; Socan, Maja ; Gijon, Manuel ; Rapp, Marie ; Havlíčková, Martina ; Trebbien, Ramona ; Guiomar, Raquel ; Hirve, Siddhivinayak S ; Buda, Silke ; van der Werf, Sylvie ; Meijer, Adam ; Fischer, Thea K. / Recommendations for respiratory syncytial virus surveillance at the national level. I: The European respiratory journal. 2021 ; Bind 58, Nr. 3.

Bibtex

@article{25d21371c4a748dd943aea9d626690ea,
title = "Recommendations for respiratory syncytial virus surveillance at the national level",
abstract = "Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infections and hospitalisations among young children and is globally responsible for many deaths in young children, especially in infants aged <6 months. Furthermore, RSV is a common cause of severe respiratory disease and hospitalisation among older adults. The development of new candidate vaccines and monoclonal antibodies highlights the need for reliable surveillance of RSV. In the European Union (EU), no up-to-date general recommendations on RSV surveillance are currently available. Based on outcomes of a workshop with 29 European experts in the field of RSV virology, epidemiology and public health, we provide recommendations for developing a feasible and sustainable national surveillance strategy for RSV that will enable harmonisation and data comparison at the European level. We discuss three surveillance components: active sentinel community surveillance, active sentinel hospital surveillance and passive laboratory surveillance, using the EU acute respiratory infection and World Health Organization (WHO) extended severe acute respiratory infection case definitions. Furthermore, we recommend the use of quantitative reverse transcriptase PCR-based assays as the standard detection method for RSV and virus genetic characterisation, if possible, to monitor genetic evolution. These guidelines provide a basis for good quality, feasible and affordable surveillance of RSV. Harmonisation of surveillance standards at the European and global level will contribute to the wider availability of national level RSV surveillance data for regional and global analysis, and for estimation of RSV burden and the impact of future immunisation programmes.",
author = "Teirlinck, {Anne C} and Broberg, {Eeva K} and Berg, {Are Stuwitz} and Harry Campbell and Reeves, {Rachel M} and AnnaSara Carnahan and Bruno Lina and Gatis Pakarna and H{\aa}kon B{\o}{\aa}s and Hanna Nohynek and Hanne-Dorthe Emborg and Harish Nair and Janine Reiche and Oliva, {Jesus Angel} and Gorman, {Joanne O} and John Paget and Karol Szymanski and Kostas Danis and Maja Socan and Manuel Gijon and Marie Rapp and Martina Havl{\'i}{\v c}kov{\'a} and Ramona Trebbien and Raquel Guiomar and Hirve, {Siddhivinayak S} and Silke Buda and {van der Werf}, Sylvie and Adam Meijer and Fischer, {Thea K}",
note = "Copyright {\textcopyright}The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org.",
year = "2021",
month = sep,
doi = "10.1183/13993003.03766-2020",
language = "English",
volume = "58",
journal = "European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "3",

}

RIS

TY - JOUR

T1 - Recommendations for respiratory syncytial virus surveillance at the national level

AU - Teirlinck, Anne C

AU - Broberg, Eeva K

AU - Berg, Are Stuwitz

AU - Campbell, Harry

AU - Reeves, Rachel M

AU - Carnahan, AnnaSara

AU - Lina, Bruno

AU - Pakarna, Gatis

AU - Bøås, Håkon

AU - Nohynek, Hanna

AU - Emborg, Hanne-Dorthe

AU - Nair, Harish

AU - Reiche, Janine

AU - Oliva, Jesus Angel

AU - Gorman, Joanne O

AU - Paget, John

AU - Szymanski, Karol

AU - Danis, Kostas

AU - Socan, Maja

AU - Gijon, Manuel

AU - Rapp, Marie

AU - Havlíčková, Martina

AU - Trebbien, Ramona

AU - Guiomar, Raquel

AU - Hirve, Siddhivinayak S

AU - Buda, Silke

AU - van der Werf, Sylvie

AU - Meijer, Adam

AU - Fischer, Thea K

N1 - Copyright ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org.

PY - 2021/9

Y1 - 2021/9

N2 - Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infections and hospitalisations among young children and is globally responsible for many deaths in young children, especially in infants aged <6 months. Furthermore, RSV is a common cause of severe respiratory disease and hospitalisation among older adults. The development of new candidate vaccines and monoclonal antibodies highlights the need for reliable surveillance of RSV. In the European Union (EU), no up-to-date general recommendations on RSV surveillance are currently available. Based on outcomes of a workshop with 29 European experts in the field of RSV virology, epidemiology and public health, we provide recommendations for developing a feasible and sustainable national surveillance strategy for RSV that will enable harmonisation and data comparison at the European level. We discuss three surveillance components: active sentinel community surveillance, active sentinel hospital surveillance and passive laboratory surveillance, using the EU acute respiratory infection and World Health Organization (WHO) extended severe acute respiratory infection case definitions. Furthermore, we recommend the use of quantitative reverse transcriptase PCR-based assays as the standard detection method for RSV and virus genetic characterisation, if possible, to monitor genetic evolution. These guidelines provide a basis for good quality, feasible and affordable surveillance of RSV. Harmonisation of surveillance standards at the European and global level will contribute to the wider availability of national level RSV surveillance data for regional and global analysis, and for estimation of RSV burden and the impact of future immunisation programmes.

AB - Respiratory syncytial virus (RSV) is a common cause of acute lower respiratory tract infections and hospitalisations among young children and is globally responsible for many deaths in young children, especially in infants aged <6 months. Furthermore, RSV is a common cause of severe respiratory disease and hospitalisation among older adults. The development of new candidate vaccines and monoclonal antibodies highlights the need for reliable surveillance of RSV. In the European Union (EU), no up-to-date general recommendations on RSV surveillance are currently available. Based on outcomes of a workshop with 29 European experts in the field of RSV virology, epidemiology and public health, we provide recommendations for developing a feasible and sustainable national surveillance strategy for RSV that will enable harmonisation and data comparison at the European level. We discuss three surveillance components: active sentinel community surveillance, active sentinel hospital surveillance and passive laboratory surveillance, using the EU acute respiratory infection and World Health Organization (WHO) extended severe acute respiratory infection case definitions. Furthermore, we recommend the use of quantitative reverse transcriptase PCR-based assays as the standard detection method for RSV and virus genetic characterisation, if possible, to monitor genetic evolution. These guidelines provide a basis for good quality, feasible and affordable surveillance of RSV. Harmonisation of surveillance standards at the European and global level will contribute to the wider availability of national level RSV surveillance data for regional and global analysis, and for estimation of RSV burden and the impact of future immunisation programmes.

UR - http://www.scopus.com/inward/record.url?scp=85115908717&partnerID=8YFLogxK

U2 - 10.1183/13993003.03766-2020

DO - 10.1183/13993003.03766-2020

M3 - Journal article

C2 - 33888523

VL - 58

JO - European Respiratory Journal

JF - European Respiratory Journal

SN - 0903-1936

IS - 3

M1 - 2003766

ER -

ID: 65157421